Remove Contamination Remove Development Remove Packaging Remove Pharma Companies
article thumbnail

Prefilled syringes and vaccines: Optimising parenteral packaging for the next pandemic

Pharmaceutical Technology

Manufacturers are actively looking at ways they can improve drug delivery through well-designed parenteral packaging systems, and the choice to deploy prefilled syringes for more and more injectable drug products is a key part of this push. Cost is an important final factor, especially for small and mid-sized pharma companies.

Packaging 130
article thumbnail

CMO Moves: Regulatory catalysts for drug manufacturing-April

Pharmaceutical Technology

In this ongoing series , we put a spotlight on contracts between pharma companies and contract manufacturing organizations (CMOs). This analysis is based on the GlobalData Pharma Intelligence Center’s Deals database and PharmSource reports.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What it takes to make cancer research more inclusive

Drug Discovery World

Anita Ramanathan examines the importance of inclusivity and diversity throughout the drug discovery and development process. . These observations may come to light in the clinic, but these disparities can be attributed to every phase of the drug development pipeline – clinical trials, translational research and, ultimately, drug discovery.

article thumbnail

Quality first: How pharma can meet injectables demand while staying compliant

Pharmaceutical Technology

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. Several drug development trends are driving injectables demand. There are additional risks to consider with parenteral packaging.